You're Reacting to Mold, but Your Doctor Says Nothing's Wrong. Here's Why.

GSTM1 is one of your body’s main phase II detoxification enzymes. Its job is to conjugate glutathione (a master antioxidant) to environmental toxins, heavy metals, and mycotoxins, making them water-soluble so they can be excreted. Without this enzyme working, toxins stay in circulation longer, accumulating in fat tissue and organs.

The GSTM1 null genotype, carried by roughly 50% of people, means the entire gene is deleted. You produce no GSTM1 enzyme at all. This is not a partial reduction; it is a complete absence. Your body loses one of its main pathways for mycotoxin clearance, and mold exposure hits harder and lingers longer.

If you have GSTM1 null, mold exposure isn’t a weekend discomfort; it becomes a multi-week burden. Symptoms linger because the toxins aren’t being cleared efficiently. Fatigue, brain fog, joint pain, and respiratory congestion don’t resolve quickly. You recover slowly from water-damaged buildings, and even minor mold exposure in food or old buildings can trigger a noticeable reaction.

GSTP1 is your other major glutathione transferase. It specializes in conjugating glutathione to oxidative stress byproducts and electrophilic compounds, protecting cells from damage when they’re exposed to toxins. GSTP1 is particularly important in the lungs and airways, where mold spores and mycotoxins first make contact.

The Ile105Val variant (Val allele), carried by roughly 35 to 40% of people, reduces GSTP1 enzyme activity. Your cells still produce the enzyme, but it works less efficiently. You can still clear mycotoxins, but at a slower rate, and under high mold exposure, your antioxidant defenses get overwhelmed faster than someone with normal GSTP1 activity.

With GSTP1 variants, respiratory symptoms tend to be prominent. You notice congestion, cough, or airway irritation more acutely in moldy spaces. Brain fog and systemic fatigue follow because oxidative stress is circulating. You recover faster than someone with GSTM1 null, but slower than someone with optimal GSTP1 activity.

SOD2 is the antioxidant guard inside your mitochondria, the power plants of your cells. When mycotoxins enter mitochondria, they generate superoxide free radicals. SOD2 converts these radicals into hydrogen peroxide, stopping cellular damage before it spreads. Without enough SOD2 activity, oxidative stress accumulates inside mitochondrial membranes, leading to energy collapse and accelerated aging of the cell.

The Val16Ala variant (homozygous Ala allele), present in roughly 40% of people of European ancestry, reduces SOD2 activity inside mitochondria. Your cells are less protected from oxidative stress generated by mycotoxins. When you’re exposed to mold, oxidative damage accumulates faster at the mitochondrial level.

If you have SOD2 Ala variants and mold exposure, fatigue is often the dominant symptom because mitochondrial energy production is compromised. You feel exhausted not just from inflammation but from cellular energy depletion. Exercise feels harder. Recovery takes longer. Brain fog is typically accompanied by that deep, unrefreshing tiredness that sleep doesn’t fix.

MTHFR is the enzyme that converts dietary folate into the active form your cells use to methylate DNA, produce glutathione, and regulate inflammation. Methylation is not optional; it’s the foundation of detoxification. If MTHFR is slow, your methylation cycle stalls, and glutathione production drops. This directly weakens your ability to conjugate and clear mycotoxins.

The C677T variant, carried by roughly 40% of people in European ancestry, reduces MTHFR enzyme efficiency by 35 to 40%. You still produce methylation intermediates, but slower. This creates a bottleneck: your detox system is trying to clear mycotoxins, but glutathione production is lagging because methylation is slow. You’re simultaneously running a detox debt and mounting an anti-inflammatory response you can’t fully fuel.

With MTHFR C677T, mold exposure doesn’t just trigger detox stress; it depletes your methylation capacity. You might notice that B vitamins or folate supplements don’t help, or that you feel worse on them, because your body can’t process standard folate efficiently. Symptoms include brain fog, mood changes, fatigue, and a sense that your recovery plateaus despite avoidance.

TNF-alpha is a master inflammatory cytokine. It’s necessary for immune response, but too much TNF-alpha driving inflammation without a brake creates systemic problems. The -308G>A variant in the TNF promoter region affects how much TNF-alpha your immune cells produce. People with the A allele tend to produce more TNF-alpha in response to immune challenges.

The A allele, carried by roughly 30% of people, increases baseline TNF-alpha production. When your immune system encounters mold spores or mycotoxins, it mounts a bigger inflammatory response. This isn’t a failure of immunity; it’s a dial turned too high. Your body is reacting appropriately to a perceived threat, but the inflammatory volume is amplified relative to the exposure.

With TNF A allele variants, mold exposure triggers prominent systemic symptoms: joint and muscle pain, malaise, low mood, and widespread inflammation that feels systemic rather than localized to airways. You feel “flu-like” after mold exposure because your TNF-alpha is circulating at higher concentrations. Fatigue is often accompanied by achiness and mood changes because TNF-alpha directly affects neurotransmitter and energy metabolism.

HLA-DQ2 is part of your immune system’s antigen-presenting machinery. It shows your immune cells which foreign molecules to attack. HLA-DQ2 is not about detoxification; it’s about how your immune system recognizes and responds to mold antigens and mycotoxins. If you carry HLA-DQ2, your immune system is wired to mount a stronger response to certain mold proteins and their metabolites.

HLA-DQ2 is carried by roughly 30 to 40% of people, depending on ancestry. The presence of HLA-DQ2 doesn’t cause mold toxicity; it increases the likelihood that your immune system will recognize mold antigens and trigger a T-cell and antibody response. This is a pattern recognition issue, not a weakness. Your immune system is doing its job, but it’s doing it more aggressively.

With HLA-DQ2, mold exposure triggers a more robust adaptive immune response. You might notice delayed symptoms appearing 12 to 48 hours after exposure, suggesting T-cell activation rather than immediate histamine release. Symptoms include fatigue, joint pain, neurological fogginess, and sometimes low-grade fever or malaise. You’re mounting an immune fight, and that costs energy and triggers inflammation.